Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:04:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:15.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 removed; v3.4.3 added.
    Difference
    0.1%
    Check dated 2026-03-11T20:20:49.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added site revision tag Revision: v3.4.2 and removed an operating-status notice (lapse in government funding) along with Revision: v3.4.1. The core study details, eligibility criteria, and trial information remain unchanged.
    Difference
    0.5%
    Check dated 2026-02-11T05:32:36.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide status notice regarding government funding and NIH operating status was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:15:07.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.